The Latin America, Middle East and Africa Spinal Muscular Atrophy Treatment Market would witness market growth of 23.3% CAGR during the forecast period (2022-2028).
To diagnose, many doctors take the blood sample of patients to check for broken or missing genes that might be responsible for SMA. Additionally, doctors can also diagnose the levels of creatine kinase (CK) enzyme that leaches out of muscles. Certain other tests can also be prescribed to ascertain the condition of SMA.
These include nerve tests (like electromyogram), computed tomography (CT), magnetic resonance imaging (MRI), as well as muscle tissue biopsy. Before the innovation of SMN replacement therapies that target genes, numerous methods have been considered to increase the levels of SMN by utilizing drugs that would target the SMN gene.
With the growing advancement in the availability of SMA treatments, this method might not be used as much, but it is still a vital method as a therapy to enhance the SMN expression in the patient. The growing incidences of SMA and the increasing approval rate of SMA-oriented gene therapy are propelling the demand for SMA treatments further.
Patients in Latin America who suffer from hereditary neuromuscular diseases (NMDs) frequently lack access to specialist medical facilities, and many of them go untreated. Due to the region's diverse healthcare system, there are differences in the general administration and care of patients with spinal muscular atrophy (SMA). Both in the public and private sectors, a dynamic new generation of clinical neurologists is being educated for the specialized treatment of SMA as well as other neuromuscular (NM) patients.
The Brazil market dominated the LAMEA Spinal Muscular Atrophy Treatment Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $131.2 million by 2028. The Argentina market is experiencing a CAGR of 23.9% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 22.9% during (2022 - 2028).
Based on Type, the market is segmented into Type 1, Type 2, Type 3 and Type 4. Based on Route of Administration, the market is segmented into Injection and Oral. Based on Treatment Type, the market is segmented into Drug and Gene Therapy. Based on Drug Type, the market is segmented into Spinraza, Zolgensma (AVXS-101), Evrysdi and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Spinal Muscular Atrophy Treatment Market is Predict to reach $11.4 Billion by 2028, at a CAGR of 17.8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Biogen, Inc., Novartis AG, Ionis Pharmaceuticals, Inc., PTC Therapeutics, Inc., NMD Pharma A/S, Scholar Rock, Inc. (Scholar Rock Holding Corporation), Cytokinetics, Inc., Biohaven Pharmaceutical Holding Company Ltd. (Pfizer, Inc.), Astellas Pharma, Inc., and F. Hoffmann-La Roche Ltd. (Genentech, Inc.)
Scope of the Study
Market Segments Covered in the Report:
By Type
By Route of Administration
By Treatment Type
- Drug
- Spinraza
- Zolgensma (AVXS-101)
- Evrysdi
- Others
- Gene Therapy
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Biogen, Inc.
- Novartis AG
- Ionis Pharmaceuticals, Inc.
- PTC Therapeutics, Inc.
- NMD Pharma A/S
- Scholar Rock, Inc. (Scholar Rock Holding Corporation)
- Cytokinetics, Inc.
- Biohaven Pharmaceutical Holding Company Ltd. (Pfizer, Inc.)
- Astellas Pharma, Inc.
- F.Hoffmann-La Roche Ltd. (Genentech, Inc.)
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Spinal Muscular Atrophy Market, by Type
1.4.2 LAMEA Spinal Muscular Atrophy Market, by Route of Administration
1.4.3 LAMEA Spinal Muscular Atrophy Market, by Treatment Type
1.4.4 LAMEA Spinal Muscular Atrophy Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Spinal Muscular Atrophy Market
Chapter 4. LAMEA Spinal Muscular Atrophy Treatment Market by Type
4.1 LAMEA Type 1 Market by Country
4.2 LAMEA Type 2 Market by Country
4.3 LAMEA Type 3 Market by Country
4.4 LAMEA Type 4 Market by Country
Chapter 5. LAMEA Spinal Muscular Atrophy Treatment Market by Route of Administration
5.1 LAMEA Injection Market by Country
5.2 LAMEA Oral Market by Country
Chapter 6. LAMEA Spinal Muscular Atrophy Treatment Market by Treatment Type
6.1 LAMEA Drug Market by Country
6.2 LAMEA Spinal Muscular Atrophy Treatment Market by Drug Type
6.2.1 LAMEA Spinraza Market by Country
6.2.2 LAMEA Zolgensma (AVXS-101) Market by Country
6.2.3 LAMEA Evrysdi Market by Country
6.2.4 LAMEA Others Market by Country
6.3 LAMEA Gene Therapy Market by Country
Chapter 7. LAMEA Spinal Muscular Atrophy Treatment Market by Country
7.1 Brazil Spinal Muscular Atrophy Treatment Market
7.1.1 Brazil Spinal Muscular Atrophy Treatment Market by Type
7.1.2 Brazil Spinal Muscular Atrophy Treatment Market by Route of Administration
7.1.3 Brazil Spinal Muscular Atrophy Treatment Market by Treatment Type
7.1.3.1 Brazil Spinal Muscular Atrophy Treatment Market by Drug Type
7.2 Argentina Spinal Muscular Atrophy Treatment Market
7.2.1 Argentina Spinal Muscular Atrophy Treatment Market by Type
7.2.2 Argentina Spinal Muscular Atrophy Treatment Market by Route of Administration
7.2.3 Argentina Spinal Muscular Atrophy Treatment Market by Treatment Type
7.2.3.1 Argentina Spinal Muscular Atrophy Treatment Market by Drug Type
7.3 UAE Spinal Muscular Atrophy Treatment Market
7.3.1 UAE Spinal Muscular Atrophy Treatment Market by Type
7.3.2 UAE Spinal Muscular Atrophy Treatment Market by Route of Administration
7.3.3 UAE Spinal Muscular Atrophy Treatment Market by Treatment Type
7.3.3.1 UAE Spinal Muscular Atrophy Treatment Market by Drug Type
7.4 Saudi Arabia Spinal Muscular Atrophy Treatment Market
7.4.1 Saudi Arabia Spinal Muscular Atrophy Treatment Market by Type
7.4.2 Saudi Arabia Spinal Muscular Atrophy Treatment Market by Route of Administration
7.4.3 Saudi Arabia Spinal Muscular Atrophy Treatment Market by Treatment Type
7.4.3.1 Saudi Arabia Spinal Muscular Atrophy Treatment Market by Drug Type
7.5 South Africa Spinal Muscular Atrophy Treatment Market
7.5.1 South Africa Spinal Muscular Atrophy Treatment Market by Type
7.5.2 South Africa Spinal Muscular Atrophy Treatment Market by Route of Administration
7.5.3 South Africa Spinal Muscular Atrophy Treatment Market by Treatment Type
7.5.3.1 South Africa Spinal Muscular Atrophy Treatment Market by Drug Type
7.6 Nigeria Spinal Muscular Atrophy Treatment Market
7.6.1 Nigeria Spinal Muscular Atrophy Treatment Market by Type
7.6.2 Nigeria Spinal Muscular Atrophy Treatment Market by Route of Administration
7.6.3 Nigeria Spinal Muscular Atrophy Treatment Market by Treatment Type
7.6.3.1 Nigeria Spinal Muscular Atrophy Treatment Market by Drug Type
7.7 Rest of LAMEA Spinal Muscular Atrophy Treatment Market
7.7.1 Rest of LAMEA Spinal Muscular Atrophy Treatment Market by Type
7.7.2 Rest of LAMEA Spinal Muscular Atrophy Treatment Market by Route of Administration
7.7.3 Rest of LAMEA Spinal Muscular Atrophy Treatment Market by Treatment Type
7.7.3.1 Rest of LAMEA Spinal Muscular Atrophy Treatment Market by Drug Type
Chapter 8. Company Profiles
8.1 PTC Therapeutics, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Acquisition and Mergers:
8.1.5.3 Approvals and Trials:
8.2 F. Hoffmann-La Roche Ltd. (Genentech, Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Approvals and Trials:
8.2.5.2 Acquisition and Mergers:
8.3 Biohaven Pharmaceutical Holding Company Ltd. (Pfizer, Inc.)
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional & Segmental Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.4 Novartis AG
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Approvals and Trials:
8.4.5.2 Acquisition and Mergers:
8.5 Ionis Pharmaceuticals, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Research & Development Expenses
8.5.4 Recent strategies and developments:
8.5.4.1 Acquisition and Mergers:
8.6 Scholar Rock, Inc. (Scholar Rock Holding Corporation)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Research & Development Expenses
8.7 Cytokinetics, Incorporated
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Research & Development Expenses
8.8 Astellas Pharma, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Regional Analysis
8.8.4 Research & Development Expense
8.9 Biogen, Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional Analysis
8.9.4 Research & Development Expense
8.10. NMD Pharma A/S
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Geographical Expansions:
TABLE 1 LAMEA Spinal Muscular Atrophy Treatment Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Spinal Muscular Atrophy Treatment Market, 2022 - 2028, USD Million
TABLE 3 LAMEA Spinal Muscular Atrophy Treatment Market by Type, 2018 - 2021, USD Million
TABLE 4 LAMEA Spinal Muscular Atrophy Treatment Market by Type, 2022 - 2028, USD Million
TABLE 5 LAMEA Type 1 Market by Country, 2018 - 2021, USD Million
TABLE 6 LAMEA Type 1 Market by Country, 2022 - 2028, USD Million
TABLE 7 LAMEA Type 2 Market by Country, 2018 - 2021, USD Million
TABLE 8 LAMEA Type 2 Market by Country, 2022 - 2028, USD Million
TABLE 9 LAMEA Type 3 Market by Country, 2018 - 2021, USD Million
TABLE 10 LAMEA Type 3 Market by Country, 2022 - 2028, USD Million
TABLE 11 LAMEA Type 4 Market by Country, 2018 - 2021, USD Million
TABLE 12 LAMEA Type 4 Market by Country, 2022 - 2028, USD Million
TABLE 13 LAMEA Spinal Muscular Atrophy Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 14 LAMEA Spinal Muscular Atrophy Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 15 LAMEA Injection Market by Country, 2018 - 2021, USD Million
TABLE 16 LAMEA Injection Market by Country, 2022 - 2028, USD Million
TABLE 17 LAMEA Oral Market by Country, 2018 - 2021, USD Million
TABLE 18 LAMEA Oral Market by Country, 2022 - 2028, USD Million
TABLE 19 LAMEA Spinal Muscular Atrophy Treatment Market by Treatment Type, 2018 - 2021, USD Million
TABLE 20 LAMEA Spinal Muscular Atrophy Treatment Market by Treatment Type, 2022 - 2028, USD Million
TABLE 21 LAMEA Drug Market by Country, 2018 - 2021, USD Million
TABLE 22 LAMEA Drug Market by Country, 2022 - 2028, USD Million
TABLE 23 LAMEA Spinal Muscular Atrophy Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 24 LAMEA Spinal Muscular Atrophy Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 25 LAMEA Spinraza Market by Country, 2018 - 2021, USD Million
TABLE 26 LAMEA Spinraza Market by Country, 2022 - 2028, USD Million
TABLE 27 LAMEA Zolgensma (AVXS-101) Market by Country, 2018 - 2021, USD Million
TABLE 28 LAMEA Zolgensma (AVXS-101) Market by Country, 2022 - 2028, USD Million
TABLE 29 LAMEA Evrysdi Market by Country, 2018 - 2021, USD Million
TABLE 30 LAMEA Evrysdi Market by Country, 2022 - 2028, USD Million
TABLE 31 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 32 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 33 LAMEA Gene Therapy Market by Country, 2018 - 2021, USD Million
TABLE 34 LAMEA Gene Therapy Market by Country, 2022 - 2028, USD Million
TABLE 35 LAMEA Spinal Muscular Atrophy Treatment Market by Country, 2018 - 2021, USD Million
TABLE 36 LAMEA Spinal Muscular Atrophy Treatment Market by Country, 2022 - 2028, USD Million
TABLE 37 Brazil Spinal Muscular Atrophy Treatment Market, 2018 - 2021, USD Million
TABLE 38 Brazil Spinal Muscular Atrophy Treatment Market, 2022 - 2028, USD Million
TABLE 39 Brazil Spinal Muscular Atrophy Treatment Market by Type, 2018 - 2021, USD Million
TABLE 40 Brazil Spinal Muscular Atrophy Treatment Market by Type, 2022 - 2028, USD Million
TABLE 41 Brazil Spinal Muscular Atrophy Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 42 Brazil Spinal Muscular Atrophy Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 43 Brazil Spinal Muscular Atrophy Treatment Market by Treatment Type, 2018 - 2021, USD Million
TABLE 44 Brazil Spinal Muscular Atrophy Treatment Market by Treatment Type, 2022 - 2028, USD Million
TABLE 45 Brazil Spinal Muscular Atrophy Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 46 Brazil Spinal Muscular Atrophy Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 47 Argentina Spinal Muscular Atrophy Treatment Market, 2018 - 2021, USD Million
TABLE 48 Argentina Spinal Muscular Atrophy Treatment Market, 2022 - 2028, USD Million
TABLE 49 Argentina Spinal Muscular Atrophy Treatment Market by Type, 2018 - 2021, USD Million
TABLE 50 Argentina Spinal Muscular Atrophy Treatment Market by Type, 2022 - 2028, USD Million
TABLE 51 Argentina Spinal Muscular Atrophy Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 52 Argentina Spinal Muscular Atrophy Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 53 Argentina Spinal Muscular Atrophy Treatment Market by Treatment Type, 2018 - 2021, USD Million
TABLE 54 Argentina Spinal Muscular Atrophy Treatment Market by Treatment Type, 2022 - 2028, USD Million
TABLE 55 Argentina Spinal Muscular Atrophy Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 56 Argentina Spinal Muscular Atrophy Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 57 UAE Spinal Muscular Atrophy Treatment Market, 2018 - 2021, USD Million
TABLE 58 UAE Spinal Muscular Atrophy Treatment Market, 2022 - 2028, USD Million
TABLE 59 UAE Spinal Muscular Atrophy Treatment Market by Type, 2018 - 2021, USD Million
TABLE 60 UAE Spinal Muscular Atrophy Treatment Market by Type, 2022 - 2028, USD Million
TABLE 61 UAE Spinal Muscular Atrophy Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 62 UAE Spinal Muscular Atrophy Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 63 UAE Spinal Muscular Atrophy Treatment Market by Treatment Type, 2018 - 2021, USD Million
TABLE 64 UAE Spinal Muscular Atrophy Treatment Market by Treatment Type, 2022 - 2028, USD Million
TABLE 65 UAE Spinal Muscular Atrophy Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 66 UAE Spinal Muscular Atrophy Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 67 Saudi Arabia Spinal Muscular Atrophy Treatment Market, 2018 - 2021, USD Million
TABLE 68 Saudi Arabia Spinal Muscular Atrophy Treatment Market, 2022 - 2028, USD Million
TABLE 69 Saudi Arabia Spinal Muscular Atrophy Treatment Market by Type, 2018 - 2021, USD Million
TABLE 70 Saudi Arabia Spinal Muscular Atrophy Treatment Market by Type, 2022 - 2028, USD Million
TABLE 71 Saudi Arabia Spinal Muscular Atrophy Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 72 Saudi Arabia Spinal Muscular Atrophy Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 73 Saudi Arabia Spinal Muscular Atrophy Treatment Market by Treatment Type, 2018 - 2021, USD Million
TABLE 74 Saudi Arabia Spinal Muscular Atrophy Treatment Market by Treatment Type, 2022 - 2028, USD Million
TABLE 75 Saudi Arabia Spinal Muscular Atrophy Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 76 Saudi Arabia Spinal Muscular Atrophy Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 77 South Africa Spinal Muscular Atrophy Treatment Market, 2018 - 2021, USD Million
TABLE 78 South Africa Spinal Muscular Atrophy Treatment Market, 2022 - 2028, USD Million
TABLE 79 South Africa Spinal Muscular Atrophy Treatment Market by Type, 2018 - 2021, USD Million
TABLE 80 South Africa Spinal Muscular Atrophy Treatment Market by Type, 2022 - 2028, USD Million
TABLE 81 South Africa Spinal Muscular Atrophy Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 82 South Africa Spinal Muscular Atrophy Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 83 South Africa Spinal Muscular Atrophy Treatment Market by Treatment Type, 2018 - 2021, USD Million
TABLE 84 South Africa Spinal Muscular Atrophy Treatment Market by Treatment Type, 2022 - 2028, USD Million
TABLE 85 South Africa Spinal Muscular Atrophy Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 86 South Africa Spinal Muscular Atrophy Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 87 Nigeria Spinal Muscular Atrophy Treatment Market, 2018 - 2021, USD Million
TABLE 88 Nigeria Spinal Muscular Atrophy Treatment Market, 2022 - 2028, USD Million
TABLE 89 Nigeria Spinal Muscular Atrophy Treatment Market by Type, 2018 - 2021, USD Million
TABLE 90 Nigeria Spinal Muscular Atrophy Treatment Market by Type, 2022 - 2028, USD Million
TABLE 91 Nigeria Spinal Muscular Atrophy Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 92 Nigeria Spinal Muscular Atrophy Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 93 Nigeria Spinal Muscular Atrophy Treatment Market by Treatment Type, 2018 - 2021, USD Million
TABLE 94 Nigeria Spinal Muscular Atrophy Treatment Market by Treatment Type, 2022 - 2028, USD Million
TABLE 95 Nigeria Spinal Muscular Atrophy Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 96 Nigeria Spinal Muscular Atrophy Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 97 Rest of LAMEA Spinal Muscular Atrophy Treatment Market, 2018 - 2021, USD Million
TABLE 98 Rest of LAMEA Spinal Muscular Atrophy Treatment Market, 2022 - 2028, USD Million
TABLE 99 Rest of LAMEA Spinal Muscular Atrophy Treatment Market by Type, 2018 - 2021, USD Million
TABLE 100 Rest of LAMEA Spinal Muscular Atrophy Treatment Market by Type, 2022 - 2028, USD Million
TABLE 101 Rest of LAMEA Spinal Muscular Atrophy Treatment Market by Route of Administration, 2018 - 2021, USD Million
TABLE 102 Rest of LAMEA Spinal Muscular Atrophy Treatment Market by Route of Administration, 2022 - 2028, USD Million
TABLE 103 Rest of LAMEA Spinal Muscular Atrophy Treatment Market by Treatment Type, 2018 - 2021, USD Million
TABLE 104 Rest of LAMEA Spinal Muscular Atrophy Treatment Market by Treatment Type, 2022 - 2028, USD Million
TABLE 105 Rest of LAMEA Spinal Muscular Atrophy Treatment Market by Drug Type, 2018 - 2021, USD Million
TABLE 106 Rest of LAMEA Spinal Muscular Atrophy Treatment Market by Drug Type, 2022 - 2028, USD Million
TABLE 107 Key Information – PTC Therapeutics, Inc.
TABLE 108 key information – F. Hoffmann-La Roche Ltd.
TABLE 109 Key Information – Biohaven Pharmaceutical Holding Company Ltd.
TABLE 110 Key Information – Novartis AG
TABLE 111 Key information – Ionis Pharmaceuticals, Inc.
TABLE 112 Key Information – Scholar Rock, Inc.
TABLE 113 Key Information – CYTOKINETICS, INCORPORATED
TABLE 114 key information – Astellas Pharma, Inc.
TABLE 115 Key Information – Biogen, Inc.
TABLE 116 Key Information – nmd pharma a/s
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: PTC Therapeutics, Inc.